Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

SOLACI-CACI 2021 | EuroPCR Session

✔️ Watch the complete PCR in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

👉 How to manage Coronary Artery Disease in patients with Severe Aortic Stenosis eligible for TAVI?

  • 04:51 – How does Coronary Artery Disease impact decision-making process of the Heart Team for patients with symptomatic severe AS? – Round Table Discussion
  • 10:59 – ACTIVATION Trial Results – Tiffany Patterson
  • 19:56 – FFR assessment of coronary stenosis found in patients eligible for a TAVI procedure: how does AS influence the measurements? Better to assess FFR before or after TAVI? – Flavio Ribichini
  • 25:40 – How to implement those results in every-day clinical practice? What about ostial RCA, LM or proximal LAD lesions? – Round Table discussion

👉 How to predict, how to avoid peri-procedural coronary obstruction during a TAVI procedure?

  • 33:04 – How to predict peri-procedural coronary obstruction during TAVI – Nicolas Dumonteil
  • 46:42 – BASILICA: technique and outcomes overview – Mohamed Abdel-Wahab
  • 55:20 – Chimney stenting technique: technique overview and results of the International registry – Darren Mylotte

👉 How to solve technical issues during PCI in a patient with a transcatheter heart valve previously implanted

  • 01:09:10 – PCI after TAVI, is it a frequent issue, what are the outcomes? – Marco Barbanti
  • 01:24:10 – My Tips and Tricks for performing a PCI in a patient having been treated by TAVI – Didier Tchétché
  • 01:33:23 – Rationale and simple technique to achieve commissural alignment during your TAVI procedure – Lars Sondergard

✔️ Chairperson: Jean Fajadet, Nicolas Dumonteil & Ernesto Ban Hayashi
✔️ Digital Moderator: Gaspar Caponi
✔️ Panelistas: Abdalla Saad, Jamil – Belardi, Jorge – Berrocal, Daniel – Gutiérrez Jaikel, Luis – Maluenda, Gabriel – Montenegro, Marcio –


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the need for repeat interventions are expected to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...